WU

Washington University School of Medicine at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Washington University School of Medicine brings 2 presentations to AMP 2026 in Seattle. Its sessions sit in haematopathology, covering copy number alterations and targeted treatment of acute myeloid leukaemia. The leukaemia work looks at menin inhibitors and resistance to targeted therapy.

Organization

AMP 2026 Attendance

WU

Washington University School of Medicine

St. Louis, MO

Med centres

Medical school in St. Louis with cancer genomics research and clinical sequencing through its McDonnell Genome Institute.

Session

Thu, Nov 12
3:00pm–3:30pm

Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting

AMP Copy Number Alterations Working Group

Copy number alterations called from sequencing: how those assays are validated, reported and read next to FISH, cytogenetics and microarray.

Ballroom E, Level 6, Arch at 705 Pike

Session

Fri, Nov 13
1:15pm–2:45pm

Menin Inhibitors and Targeted Therapy Resistance in AML

608-609, Level 6, Arch at 705 Pike

Hematopathology

1:15pm–2:00pmMenin Inhibitor Use in Acute Myeloid LeukemiaJohns Hopkins
2:00pm–2:45pmDevelopment and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid LeukemiaUniversity of Michigan

Instantly find 20 buyers from Washington University School of Medicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction